Squarepoint
OKUR icon

Squarepoint’s OnKure Therapeutics OKUR Stock Holding History

Squarepoint’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78.4K Buy
+28,778
New +$109K ﹤0.01% 4248
2024
Q4 		– Sell
-1,103
Closed -$18.8K – 5590
2024
Q3 		$18.8K Sell
1,103
-846
-43% -$12.5K ﹤0.01% 4025
2024
Q2 		$29.4K Buy
+1,949
New +$33K ﹤0.01% 3944

Other funds holding OKUR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Squarepoint's OKUR Position: Q3 2026 in Review

Squarepoint opened a new position in OnKure Therapeutics (OKUR) in Q3 2026: 28,778 shares worth $78.4K. The stake represents ﹤0.01% of the portfolio and ranks #4248 among its holdings. This is a return to the name: Squarepoint previously reported a position in OKUR as recently as Q3 2024.

Squarepoint first reported a position in OKUR in Q2 2024 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

  • Squarepoint held 28,778 shares of OnKure Therapeutics worth $78.4K as of Q3 2026.
  • OnKure Therapeutics was a new Squarepoint position in Q3 2026.
  • OnKure Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4248 holding.
  • Squarepoint first reported a position in OnKure Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.